Cargando…

Correlation and prognostic accuracy between noninvasive liver fibrosismarkers and portal pressure in cirrhosis: Role of ALBI score

BACKGROUND: The role of noninvasive liver fibrosis markers which were developed to evaluate the severity of chronic liver disease remains unclear in cirrhosis. AIMS: To evaluate the correlation between noninvasive markers and hemodynamic parameters and their prognostic performance in cirrhotic patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hsieh, Yun-Cheng, Lee, Kuei-Chuan, Wang, Ying-Wen, Yang, Ying-Ying, Hou, Ming-Chih, Huo, Teh-Ia, Lin, Han-Chieh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6291250/ https://www.ncbi.nlm.nih.gov/pubmed/30540824 http://dx.doi.org/10.1371/journal.pone.0208903

Ejemplares similares

Comparative evaluation of ALBI, MELD, and Child-Pugh scores in prognosis of cirrhosis: is ALBI the new alternative?
por: Fragaki, Maria, et al.
Publicado: (2019)

Prognostic Prediction for Patients with Hepatocellular Carcinoma and Ascites: Role of Albumin-Bilirubin (ALBI) Grade and Easy (EZ)-ALBI Grade
por: Liao, Jia-I, et al.
Publicado: (2023)

Comparison of Four Albumin-Based Liver Reserve Models (ALBI/EZ-ALBI/PALBI/PAL) against MELD for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
por: Ho, Shu-Yein, et al.
Publicado: (2023)

Accuracy of noninvasive tests in the prediction of portal hypertensive gastropathy in Egyptian patients with cirrhosis
por: Amer, Ibrahim F, et al.
Publicado: (2021)

In albis : poemas, 1979-1990 /
por: Magaña, Gabriel, 1944-

Glucobrassicin Metabolites Ameliorate the Development of Portal Hypertension and Cirrhosis in Bile Duct-Ligated Rats
por: Chang, Ting, et al.
Publicado: (2019)

ALBI SCORE AS A PREDICTOR OF SURVIVAL IN PATIENTS WITH COMPENSATED CIRRHOSIS RESECTED FOR HEPATOCELLULAR CARCINOMA: EXPLORATORY EVALUATION IN RELATIONSHIP TO PALBI AND MELD LIVER FUNCTION SCORES
por: Božin, Tonći, et al.
Publicado: (2018)

AN EXPERIMENTAL STUDY INTO THE CAUSE OF THE INCREASED PORTAL PRESSURE IN PORTAL CIRRHOSIS
por: Herrick, Frederick C.
Publicado: (1907)

Combined APRI/ALBI score to predict mortality after hepatic resection
por: Starlinger, P, et al.
Publicado: (2021)

Diagnostic and Prognostic Values of Noninvasive Predictors of Portal Hypertension in Patients with Alcoholic Cirrhosis
por: Cho, Eun Ju, et al.
Publicado: (2015)

ALBI Score Is a Strong Predictor of Toxicity Following SIRT for Hepatocellular Carcinoma
por: Lescure, Céline, et al.
Publicado: (2021)

Application of the ALBI Scoring System for Mortality Outcome Prediction in Patients with Hypertrophic Cardiomyopathy
por: Qiao, Ping, et al.
Publicado: (2022)

Diagnostic efficacy of noninvasive liver fibrosis indexes in predicting portal hypertension in patients with cirrhosis
por: Wang, Le, et al.
Publicado: (2017)

Eritoran Attenuates Hepatic Inflammation and Fibrosis in Mice with Chronic Liver Injury
por: Hsieh, Yun-Cheng, et al.
Publicado: (2021)

The ability of the new ALBI scoring in predicting mortality, complications and prognostic comparison among cirrhotics
por: Naqvi, Iftikhar Haider, et al.
Publicado: (2019)

The Relationship and Changes of Liver Blood Supply, Portal Pressure Gradient, and Liver Volume following TIPS in Cirrhosis
por: He, Jinghong, et al.
Publicado: (2022)

Relationship between hemodynamic parameters and portal venous pressure in cirrhosis patients with portal hypertension
por: Yao, Hongjuan, et al.
Publicado: (2020)

An ALBI- and Ascites-Based Model to Predict Survival for BCLC Stage B Hepatocellular Carcinoma
por: He, Cheng, et al.
Publicado: (2022)

The ALBI score: From liver function in patients with HCC to a general measure of liver function
por: Toyoda, Hidenori, et al.
Publicado: (2022)

Intestinal and plasma VEGF levels in cirrhosis: the role of portal pressure
por: Huang, Hui-Chun, et al.
Publicado: (2012)

Ability of the post-operative ALBI grade to predict the outcomes of hepatocellular carcinoma after curative surgery
por: Cho, Wei-Ru, et al.
Publicado: (2020)

Emricasan (IDN‐6556) Lowers Portal Pressure in Patients With Compensated Cirrhosis and Severe Portal Hypertension
por: Garcia‐Tsao, Guadalupe, et al.
Publicado: (2018)

Noninvasive scores for the prediction of esophageal varices and risk stratification in patients with cirrhosis
por: Bangaru, Saroja, et al.
Publicado: (2020)

The Accuracy of Ultrasonography for the Evaluation of Portal Hypertension in Patients with Cirrhosis: A Systematic Review
por: Kim, Gaeun, et al.
Publicado: (2015)

Child Pugh and ALBI grade: past, present or future?
por: Rimini, Margherita, et al.
Publicado: (2020)

A Preclinical Porcine Model of Portal Vein Thrombosis in Liver Cirrhosis
por: Zhang, Rui, et al.
Publicado: (2020)

Prognostic Role of Albumin, Bilirubin, and ALBI Scores: Analysis of 1000 Patients with Hepatocellular Carcinoma Undergoing Radioembolization
por: Antkowiak, Mark, et al.
Publicado: (2019)

Albumin-bilirubin (ALBI) score at admission predicts possible outcomes in patients with acute-on-chronic liver failure
por: Chen, Bo, et al.
Publicado: (2017)

MELD-Sarcopenia is Better than ALBI and MELD Score in Patients with Hepatocellular Carcinoma Awaiting Liver Transplantation
por: Alsebaey, Ayman, et al.
Publicado: (2021)

Using AI and Gd-EOB-DTPA-enhanced MR imaging to assess liver function, comparing the MELIF score with the ALBI score
por: Río Bártulos, Carolina, et al.
Publicado: (2023)

Effect of Transarterial Chemoembolization on ALBI Grade in Intermediate-Stage Hepatocellular Carcinoma: Criteria for Unsuitable Cases Selection
por: Chi, Chen-Ta, et al.
Publicado: (2021)

The Association of Albumin-Bilirubin (ALBI) Grade with Mortality Risk in Trauma Patients with Liver Injuries
por: Chou, Sheng-En, et al.
Publicado: (2023)

ALBI score and outcomes in patients with hepatocellular carcinoma: post hoc analysis of the randomized controlled trial KEYNOTE-240
por: Vogel, Arndt, et al.
Publicado: (2021)

Mac-2 binding protein glycosylation isomer is a potential biomarker to predict portal hypertension and bacterial infection in cirrhotic patients
por: Wu, Pei-Shan, et al.
Publicado: (2021)

Público y privado : un acuerdo necesario / Emilio Albi.
por: Albi Ibáñez, Emilio
Publicado: (2000)

Down-regulation of common NFκB-iNOS pathway by chronic Thalidomide treatment improves Hepatopulmonary Syndrome and Muscle Wasting in rats with Biliary Cirrhosis
por: Li, Tzu-Hao, et al.
Publicado: (2016)

The kidney in cirrhosis with portal hypertension
por: Olteanu, D, et al.
Publicado: (2010)

Serum levels of bone sialoprotein correlate with portal pressure in patients with liver cirrhosis
por: Benz, Fabian, et al.
Publicado: (2020)

Extrahepatic Surgery in Cirrhosis Significantly Increases Portal Pressure in Preclinical Animal Models
por: Chang, Johannes, et al.
Publicado: (2021)

The Effectiveness of Noninvasive Biomarkers to Predict Hepatitis B-Related Significant Fibrosis and Cirrhosis: A Systematic Review and Meta-Analysis of Diagnostic Test Accuracy
por: Xu, Xue-Ying, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_dm9tt15s5dd5pd8lu7deidg801